ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Bioventus Inc

Bioventus Inc (BVS)

6.07
0.08
( 1.34% )
Updated: 10:15:32

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
6.07
Bid
6.06
Ask
6.07
Volume
54,609
5.78 Day's Range 6.10
1.12 52 Week Range 6.115
Market Cap
Previous Close
5.99
Open
5.99
Last Trade
40
@
6.07
Last Trade Time
10:15:32
Financial Volume
$ 329,996
VWAP
6.0429
Average Volume (3m)
229,417
Shares Outstanding
79,165,540
Dividend Yield
-
PE Ratio
-3.07
Earnings Per Share (EPS)
-1.97
Revenue
512.35M
Net Profit
-156.23M

About Bioventus Inc

Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, in... Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Show more

Sector
Surgical,med Instr,apparatus
Industry
Surgical,med Instr,apparatus
Headquarters
Wilmington, Delaware, USA
Founded
1970
Bioventus Inc is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker BVS. The last closing price for Bioventus was $5.99. Over the last year, Bioventus shares have traded in a share price range of $ 1.12 to $ 6.115.

Bioventus currently has 79,165,540 shares outstanding. The market capitalization of Bioventus is $479.74 million. Bioventus has a price to earnings ratio (PE ratio) of -3.07.

BVS Latest News

Bioventus Reports First Quarter Financial Results

Raises Full-Year 2024 Financial Guidance Reflecting Enhanced Revenue Growth and Strong Execution of Strategic PrioritiesAccelerated First Quarter Revenue Growth by 8.7%, Organic Growth* by...

Bioventus to Report First Quarter of Fiscal Year 2024 Financial Results on May 7, 2024

DURHAM, N.C., April 29, 2024 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will...

Bioventus Announces Fourth Quarter and Full Year 2023 Financial Results

Accelerated fourth quarter sales growth to 7.6%, organic growth* of 14.3%Appointed Rob Claypoole as President and Chief Executive Officer, bringing more than 20 years of leadership experience in...

Bioventus to Report Fourth Quarter of Fiscal Year 2023 Financial Results on March 12, 2024

DURHAM, N.C., March 04, 2024 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.6712.40740740745.46.1154.515069895.46169572CS
41.429.97858672384.676.1153.93654705.04884301CS
121.5233.40659340664.556.1153.92294175.09395209CS
262.0751.7546.1153.641962234.89767336CS
524.86401.6528925621.216.1151.123403373.4498261CS
156-9.95-62.109862671716.0219.94090.79993750155.21758452CS
260-9.03-59.801324503315.119.94090.79993645915.73307066CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
SINTSiNtx Technologies Inc
$ 0.1443
(162.36%)
419.67M
AWINAERWINS Technologies Inc
$ 7.085
(161.44%)
19.46M
FFIEFaraday Future Intelligent Electric Inc
$ 0.488099
(71.14%)
389.52M
IPWiPower Inc
$ 1.3297
(50.48%)
2.92M
SLNASelina Hospitality PLC
$ 0.084
(50.00%)
100.76M
VRPXVirpax Pharmaceuticals Inc
$ 0.84
(-63.32%)
1.04M
YTENYield10 Bioscience Inc
$ 2.54
(-51.71%)
164.87k
AEMDAethlon Medical Inc
$ 0.466
(-45.18%)
3.38M
PXLWPixelworks Inc
$ 1.10
(-41.18%)
3.67M
BOLTBolt Biotherapeutics Inc
$ 0.8737
(-33.81%)
1.53M
SINTSiNtx Technologies Inc
$ 0.1443
(162.36%)
419.67M
FFIEFaraday Future Intelligent Electric Inc
$ 0.488099
(71.14%)
389.52M
GWAVGreenwave Technology Solutions Inc
$ 0.0555
(24.72%)
332.15M
CRKNCrown Electrokinetics Corporation
$ 0.052
(9.24%)
122.31M
SLNASelina Hospitality PLC
$ 0.084
(50.00%)
100.76M

BVS Discussion

View Posts
tw0122 tw0122 1 week ago
Durolane like it .. older news ..Bioventus Agrees to Nationwide Contract with Aetna™ Medicare Advantage Plans for DUROLANE® for Knee Osteoarthritis

Source: GlobeNewswire Inc.

Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has agreed to a nationwide contract with Aetna™ Medicare Advantage plans. Beginning January 1, 2024, over 3 million Aetna™ Medicare Advantage plan members will have access to DUROLANE to treat knee osteoarthritis (OA) pain. DUROLANE, is a single-injection hyaluronic acid (HA)-based joint-fluid treatment for patients. DUROLANE will be one of two single-injection HA products under contract.
OA involves the breakdown, or degeneration, of cartilage and the synovial fluid that cushions and lubricates joint tissues. Injection treatments of HA-based products, such as DUROLANE, help manage knee OA pain.

“We are pleased DUROLANE is among the preferred options available to both Aetna™ Medicare Advantage members and physicians,” said Anthony Doyle, General Manager, Pain Treatments and Restorative Therapies for Bioventus. “Both now have access to a safe HA product that is proven to provide relief from knee OA pain.”

About Bioventus

Bioventus delivers clinically proven, cost-effective products that help people heal quickly and safely. Its mission is to make a difference by helping patients resume and enjoy active lives. The Innovations for Active Healing from Bioventus include offerings for Pain Treatments, Restorative Therapies and Surgical Solutions. Built on a commitment to high quality standards, evidence-based medicine and strong ethical behavior, Bioventus is a trusted partner for physicians worldwide. For more information, visit www.bioventus.com, and follow the Company on LinkedIn and Twitter. Bioventus and the Bioventus logo are registered trademarks of Bioventus LLC.

👍️0
TheFinalCD TheFinalCD 1 week ago
$BVS - Bioventus GAAP EPS of -$0.07 beats by $0.18, revenue of $129.45M beats by $11.07M https://t.co/IGk1Zy2r5X— Seeking Alpha Market News (@MarketCurrents) May 7, 2024
👍️0
Monksdream Monksdream 4 weeks ago
BVS under $5

👍️0